Navigation Links
Sangamo BioSciences Announces Presentation at Seventh Annual JMP Securities Healthcare Conference
Date:7/3/2012

RICHMOND, Calif., July 3, 2012 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today that Edward Lanphier, Sangamo's president and CEO, will provide an update on the progress of Sangamo's ZFP Therapeutic® development programs and an overview of the company's business strategy at 10:00 am ET on Thursday, July 12, 2012, at the Seventh Annual JMP Securities Healthcare Conference which will be held in New York City.

The presentation will be webcast live and may be accessed via a link on the Sangamo BioSciences website in the Investor Relations section http://investor.sangamo.com/index.cfm under Events and Presentations. The presentation will be archived on the Sangamo website for two weeks after the event.

About Sangamo Sangamo BioSciences, Inc. is focused on research and development of novel DNA-binding proteins for therapeutic gene regulation and genome editing. It has ongoing Phase 2 and Phase 1/2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS.  Sangamo's other therapeutic programs are focused on monogenic diseases, including hemophilia and  hemoglobinopathies such as sickle cell anemia and beta-thalassemia, and a program in Parkinson's disease. Sangamo's core competencies enable the engineering of a class of DNA-binding proteins known as zinc finger DNA-binding proteins (ZFPs).  Engineering of ZFPs that recognize a specific DNA sequence enables the creation of sequence-specific ZFP Nucleases (ZFNs) for gene modification and ZFP transcription factors (ZFP TFs) that can control gene expression and, consequently, cell function. Sangamo has entered into a strategic collaboration with Shire to develop therapeutics for hemophilia and other monogenic diseases and has established strategic partnerships wit
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
2. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
3. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
4. Sangamo BioSciences Announces First Quarter 2012 Conference Call and Webcast
5. Sangamo BioSciences Reports First Quarter 2012 Financial Results
6. Sangamo BioSciences Announces Presentations At Upcoming Investor Conferences
7. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
8. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
9. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
10. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
11. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 Oven Industries Inc. announces ... 5R6-900 temperature controller has many user-friendly benefits. Contained all ... the wall as a self-contained temperature control ... detail makes the device unique, as well as highly ... also be used universally, which allows the user to ...
(Date:5/17/2013)... UK (PRWEB) May 17, 2013 The ... Photonics21 at the association’s recent annual meeting ... including EC Vice-President Neelie Kroes, who called the action ... sectors, and a stimulant to European innovation.” , The ... structure of the new Photonics PPP at its 29 ...
(Date:5/17/2013)... -- Yongye International, Inc. (NASDAQ: YONG ) ("Yongye" ... of crop nutrient products in the People,s ... May 16, 2013, the special committee (the "Special Committee") ... was provided a letter (the "Letter") issued by Abax ... ("Abax") to Full Alliance International Limited ("Full Alliance"). The ...
(Date:5/17/2013)... The paradigm of ‘one drug, one target’ has ... predict the adverse and therapeutic effects of a drug. ... Biology at the Genomics Laboratory, Covance, will discuss the ... when used as part of the QC process. Additionally, ... to identify key clinical targets even in complex data ...
Breaking Biology Technology:New Temperature Control Products Announced by Oven Industries Inc. 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 2SPIE Joins in Praise for ‘Huge Step Forward’ for Innovation R&D Enabled by Photonics21 Actions 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4
... the world,s leading,online bioscience job board and life ... Career Fair in Chicago, IL on Tuesday April ... Chicago Marriott Oak Brook from 11 am to ... Midwest life science professionals from states like ...
... Do You Have the Guts?, aims to reach five ... Quest Diagnostics,Incorporated (NYSE: DGX ), the nation,s ... the launch of a novel,campaign designed to help increase ... Challenge Colon Cancer: Do You Have,the Guts?," the campaign ...
... of elderly patients could cut their total,mortality by a ... third,according to a new study presented today at the ... the New England,Journal of Medicine., LONDON, March 31 ... (HYVET), which is co-ordinated by scientists from,Imperial College London, ...
Cached Biology Technology:Chicago Biotech Career Fair to Draw Hundreds of Bioscience Candidates and Top Employers 2Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo 2Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo 3Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo 4Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over 2Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over 3Significant Reductions in Mortality and Cardiovascular Events Shown Using Blood Pressure-Lowering Treatment in Those Aged 80 and Over 4
(Date:5/17/2013)... finds human-caused climate change may have little impact ... host of recent studies that predict their widespread ... findings, which appear in the journal Global ... of a creature thought to be doomed: ... animals, especially forest lizards, will be hard hit ...
(Date:5/16/2013)... (Maximizing Access to Research Careers) Program has announced ... Developmental Biology (SDB) 72nd Annual Meeting in Cancun, ... meant to promote the entry of students, postdoctorates ... of the basic science community and to encourage ... 2013 Annual Meeting. , Awards are given to ...
(Date:5/16/2013)... BOSTON The endothelium, the cellular layer lining ... just a few hundred nanometers in thickness, this ... stretch and tissue compression to create a unique ... necessary to partition tissues from the body,s circulatory ... when the barrier must be physically breached ...
Breaking Biology News(10 mins):Climate change may have little impact on tropical lizards 2Endothelium, heal thyself 2Endothelium, heal thyself 3Endothelium, heal thyself 4
... food preferences so that they eat less high fat ... at Imperial College London. The findings, published in the ... , suggest a new mechanism by which some types ... A growing number of obese patients are choosing to ...
... gastric bypass, the most common type of bariatric surgery ... effective therapy for morbid obesity. Patients who undergo this ... small pouch and connected to the middle of the ... the reasons behind this surgery,s success have been unclear. ...
... COLLEGE PARK, Md. "Brain cap" technology being ... turn their thoughts into motion. Associate Professor of Kinesiology ... a non-invasive, sensor-lined cap with neural interface software that ... limbs, motorized wheelchairs and even digital avatars. "We ...
Cached Biology News:Gastric bypass surgery changes food preferences 2Study suggests weight loss from gastric bypass may be partly due to dietary fat aversion 2Study suggests weight loss from gastric bypass may be partly due to dietary fat aversion 3UMD brain cap technology turns thought into motion 2UMD brain cap technology turns thought into motion 3UMD brain cap technology turns thought into motion 4UMD brain cap technology turns thought into motion 5
... g of lyophilized peptide derived from the ... 380-402; GLTPSAWEASSLRSSRHSGLSHF. This peptide was ... Cayman's EP1 receptor polyclonal antibody (Catalog No. ... with this antibody to block protein-antibody complex ...
... 75 x ... recommended for immunohistochemistry of paraffin-embedded sections, ... at one end, markings ... normal procedures, precleaned, ...
Complete cell culture media with cytokines...
HAS1 (C-14)...
Biology Products: